Research on longevity, or fighting aging as a disease, has several things in the way of its progress. These range from technical complexity, to regulatory barriers, to negative public perceptions and misunderstandings of life extension. The largest hurdle, however, is funding. It’s difficult to deny the profound impact more funding would have on discoveries made and advances achieved in the field of aging. [1,2,3] More funding means more shots on goal, but innovation on how that funding is deployed is also desperately needed.

The current state of biomedical research funding is a fraught topic, every step of the way. In…


VitaDAO is the world’s first decentralized intellectual property collective, funding and commissioning research into human longevity.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store